The Green Organic Dutchman (TSX:TGOD) Stock Continues to Fall in October

Is there more mayhem in store for The Green Organic Dutchman shareholders after a 40% fall in October?

Businessmen teamwork brainstorming meeting.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Shares of The Green Organic Dutchman (TSX:TGOD) fell over 3.3% on October 21, 2019. The stock is currently trading at $1.15, which is 80% below its 52-week high of $5.81. TGOD has almost 45% in market value this month and has burnt significant investor wealth.

TGOD investors have become increasingly wary of the stock ever since Aurora Cannabis sold its 10.5% stake in the company last month. On October 9, TGOD’s management also announced that it is struggling to raise debt capital on favourable terms resulting in a significant sell-off of company stock.

TGOD’s press release had then stated, “As previously disclosed, the company had been engaged in discussions for ordinary course commercial bank facilities and equipment leasing.

However, because of changing market conditions, those sources of financing have been unavailable on acceptable terms within the time frames required, leading the company to commence a review of additional alternatives.”

But if TGOD is unable to raise the required capital, it will have to revise the construction schedule of its licensed facilities at Ancaster and Valleyfield. TGOD’s Ancaster facility is close to competition and has supply agreements with Canadian provinces of Ontario, Alberta and British Columbia.

TGOD announced that debt capital will also be used ramp up production and build its product portfolio to be ready for cannabis 2.0. Cannabis-infused edibles, vapes, and concentrates will be available for retail purchase starting December 16, 2019.

Several cannabis companies are finding it difficult to raise debt funding from U.S.-based banks, as cannabis is still illegal at the federal level, and as a result, banks are unwilling to pump in millions of dollars.

TGOD will cut its capital expenditure

TGOD stock has been trading lower over the last two days after the company unveiled a strategic plan to reduce financing requirements and grow profitability as it continues to look for capital.

The company believes these plans will lower capital expenditure and result in optimal production capacity. TGOD is optimistic about achieving positive cash flow by the second quarter of fiscal 2020 (year ending in July).

It also stated that the Ancaster greenhouse is complete while the processing facility is five weeks away from completion. TGOD’s Valleyfield facility will be “demarcated into smaller phases, with more to be completed once the market further develops.”

These two facilities will increase TGOD production between 20,000 kilograms and 22,000 kilograms of cannabis in 2020. TGOD has also employed a strategic advisor to evaluate funding options and raise between $70 million and $80 million.

There’s a good chance that TGOD will have to dig into operating cash flow to fund its projects. It also claimed that it can raise funds after proven sales from the Ancaster facility. TGOD has attributed the lower capex forecast to the slow rollout of retail locations in major Canadian provinces — this forecast sent cannabis stocks lower on Friday.

The company like several other cannabis peers seems to have overestimated the legal marijuana market, which is struggling with cannibalization from illegal sellers.

TGOD ready for cannabis 2.0

TGOD has announced that it’s ready to commercialize cannabis-infused products such as organic teas, vapes and others by mid-December. It’s working with several co-packers to launch liquid beverages and topicals in 2020 after Health Canada licenses these facilities.

Will TGOD’s race to profitability result in a boost in stock price? Well, the company first needs to move closer to operating profitability in the October quarter to keep investors interested.

Analysts remain optimistic about TGOD stock with a 12-month price target of $3.28 for the stock, which is 185% above the current trading price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »